Avelumab is a fully human monoclonal antibody which has been used in clinical trials to treat mesothelioma and other cancers. In this video from OncLiveTV shared in October 2015, Dr. Raffit Hassan from the National Cancer Institute discusses the results of a clinical trial for avelumab for unresectable mesothelioma.
According to Mesothelioma Online, unresectable mesothelioma occurs when doctors decide that surgery will not remove all the tumors. This usually occurs with later stage mesothelioma, but can occur in earlier stages as well. In cases of unresectable mesothelioma, doctors and patients will choose an alternative form of therapy which may include radiotherapy, chemotherapy, and medications or a combination of therapies.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.